Open access
Sep 2026
Nine-month all-oral regimen for MDR/RR-TB in Lesotho: safety and effectiveness by HIV
Background: Individuals living with HIV have been under-represented in operational research and trials of all-oral regimens for multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) treatment. We report outcomes from a prospective observational cohort study of a nine-month regimen comprised of bedaquiline, linez...
S. Sauer, S. Mpinda, A. Lahood et al.
· medRxiv · 0 citations